Skip to content

Q1 FY27 Earnings Results

Q1 FY27 earnings, Apr–Jun 2026: 4,798 Indian listed companies have reported; median profit growth is +16.0% on last year, and 220 of 409 companies with analyst estimates beat them. Quarter ended 30 Jun 2026.

Clear filters 1–100 of 222
CompanyRevenue (₹ Cr)Profit (₹ Cr)Per share8Q profit
Symbol Sector Reported YoY QoQ Reported YoY EPS vs consensus Trend
SUNPHARMA Sun Pharmaceutical Industries LtdHealthcare15,300up+10.5%up+4.7%2,901up+26.5%12.06In line −0.1% est. 12.11
AUROPHARMA Aurobindo Pharma LtdHealthcare9,150up+16.3%up+3.4%1,032up+25.2%17.95Beat +5.8% est. 16.88
LUPIN Lupin LtdHealthcare8,277up+32.0%up+10.7%1,417up+16.1%30.95Beat +5.6% est. 29.31
DRREDDY Dr Reddys Laboratories LtdHealthcare8,100down−5.5%up+7.3%436down−69.1%5.32Miss −39.8% est. 8.86
ZYDUSLIFE Zydus Lifesciences LtdHealthcare8,017up+22.0%up+5.7%990down−34.9%9.42Miss −14.4% est. 10.93
CIPLA Cipla LtdHealthcare7,119up+2.3%up+8.8%786down−39.2%9.77Miss −7.7% est. 10.59
TORNTPHARM Torrent Pharmaceuticals LtdHealthcare4,921up+54.8%up+17.3%566up+3.3%16.72In line −1.2% est. 15.06
BIOCON Biocon LtdHealthcare4,336up+10.0%down−4.0%137up+53.7%0.87Miss −6.7% est. 0.93
MANKIND Mankind Pharma LtdHealthcare4,031up+12.9%up+17.1%574up+29.0%13.75Beat +3.8% est. 13.26
GLENMARK Glenmark Pharmaceuticals LtdHealthcare4,018up+23.1%up+6.5%483up+927.7%17.11Beat +2.5% est. 16.70
ALKEM Alkem Laboratories LtdHealthcare3,740up+11.0%up+3.8%521down−22.0%43.49Beat +27.2% est. 34.20
MANIPALHOS Manipal Health Enterprises LtdHealthcare3,091up+277.8%up+219.6%243up+93.2%0.98Beat +7.8% est. 1.82
DIVISLAB Divis Laboratories LtdHealthcare3,080up+27.8%up+8.8%902up+65.5%33.98Beat +41.4% est. 24.01
IPCALAB Ipca Laboratories LtdHealthcare2,788up+20.7%up+16.8%424up+82.1%15.84Beat +42.7% est. 11.10
EMCURE Emcure Pharmaceuticals LtdHealthcare2,580up+22.8%up+4.5%292up+36.0%15.50Beat +23.0% est. 12.60
PPLPHARMA Piramal Pharma LtdHealthcare2,270up+17.4%down−17.5%−69n/a−0.52Beat +36.2% est. −0.82
JUBLPHARMA Jubilant Pharmova LtdHealthcare2,229up+17.3%down−2.6%56down−44.7%3.55No estimate
APLLTD Alembic Pharmaceuticals LtdHealthcare2,150up+25.6%up+16.3%172up+11.9%8.80Beat +17.3% est. 7.50
LAURUSLABS Laurus Labs LtdHealthcare2,026up+29.0%up+11.8%362up+123.5%6.80Beat +52.7% est. 4.46
ABBOTINDIA Abbott India LtdHealthcare1,814up+4.4%up+6.1%429up+17.2%201.66In line −0.6% est. 202.90
GLAND Gland Pharma LtdHealthcare1,800up+19.5%up+3.3%317up+47.4%19.21Beat +10.0% est. 17.49
AJANTPHARM Ajanta Pharma LtdHealthcare1,626up+24.8%up+14.3%334up+31.0%26.75Beat +16.3% est. 23.00
GRANULES Granules India LtdHealthcare1,477up+22.1%up+0.4%180up+59.3%7.26No estimate
STAR Strides Pharma Science LtdHealthcare1,265up+12.9%down−4.4%165up+55.7%17.02No estimate
AKUMS Akums Drugs & Pharmaceuticals LtdHealthcare1,167up+13.9%up+0.7%101up+55.4%6.35Beat +7.0% est. 6.10
INDGN Indegene LtdHealthcare1,063up+39.7%up+6.0%1160.0%4.82Beat +3.0% est. 4.70
VIYASH Viyash Scientific LtdHealthcare946up+19.5%up+2.9%79up+114.3%1.51Miss −24.5% est. 2.00
GLAXO Glaxosmithkline Pharmaceuticals LtdHealthcare938up+16.6%down−5.7%237up+15.7%14.00In line +0.7% est. 13.90
WOCKPHARMA Wockhardt LtdHealthcare929up+25.9%down−3.7%107n/a6.52No estimate
ERIS ERIS Lifesciences LtdHealthcare873up+12.9%up+15.3%143up+14.4%10.28Miss −6.5% est. 11.00
MARKSANS Marksans Pharma LtdHealthcare841up+35.6%down−1.8%159up+174.8%3.47No estimate
IOLCP IOL Chemicals & Pharmaceuticals LtdHealthcare756up+37.0%up+22.2%64up+89.4%2.20No estimate
SYNGENE Syngene International LtdHealthcare736down−15.8%down−29.0%−9down−110.4%−0.22Miss −115.1% est. 1.46
NATCOPHARM Natco Pharma LtdHealthcare735down−44.7%down−0.5%207down−57.0%10.52No estimate
AARTIDRUGS Aarti Drugs LtdHealthcare703up+19.0%down−2.4%50down−7.4%5.50No estimate
ASTRAZEN Astrazeneca Pharma India LtdHealthcare683up+29.8%up+17.9%38down−32.3%15.17No estimate
DCAL Dishman Carbogen Amcis LtdHealthcare678down−4.3%down−20.4%−58down−351.7%−3.69No estimate
FDC FDC LtdHealthcare668up+3.0%up+14.1%132up+9.5%8.14No estimate
PFIZER Pfizer LtdHealthcare653up+8.3%up+3.8%204up+6.3%44.70In line −1.1% est. 45.20
NEULANDLAB Neuland Laboratories LtdHealthcare642up+119.0%down−17.3%148up+954.8%115.10Beat +91.8% est. 60.01
ALIVUS Alivus Life Sciences LtdHealthcare640up+6.3%down−7.1%160up+31.1%13.04Beat +7.8% est. 12.10
UNICHEMLAB Unichem Laboratories LtdHealthcare633up+20.0%up+10.0%41n/a5.89No estimate
CAPLIPOINT Caplin Point Laboratories LtdHealthcare610up+19.7%up+1.7%179up+18.6%23.27No estimate
MOREPENLAB Morepen Laboratories LtdHealthcare570up+34.1%up+17.6%56up+412.7%1.03No estimate
SAILIFE Sai Life Sciences LtdHealthcare554up+11.8%down−7.9%73up+22.1%3.45Miss −2.5% est. 3.55
AARTIPHARM Aarti Pharmalabs LtdHealthcare536up+38.8%down−8.1%76up+52.3%8.40No estimate
RUBICON Rubicon Research LtdHealthcare534up+51.8%up+4.0%85up+97.2%5.13No estimate
POLYMED Poly Medicure LtdHealthcare525up+30.4%down−1.8%85down−8.3%8.49Beat +30.6% est. 6.50
INNOVACAP Innova Captab LtdHealthcare471up+33.8%up+5.1%44up+42.3%7.71Beat +126.8% est. 3.40
INDOCO Indoco Remedies LtdHealthcare468up+6.4%down−1.7%65n/a7.04No estimate
SHILPAMED Shilpa Medicare LtdHealthcare466up+45.1%up+6.6%101up+114.6%5.16No estimate
ONESOURCE OneSource Specialty Pharma LtdHealthcare449up+37.3%up+4.9%25n/a2.18No estimate
SANOFI Sanofi India LtdHealthcare438up+7.8%down−7.3%84up+19.3%36.30No estimate
COHANCE Cohance Lifesciences LtdHealthcare422down−23.1%down−31.8%−45down−198.2%−0.63Beat +10.0% est. −0.70
CORONA Corona Remedies LtdHealthcare422up+21.6%up+19.5%60up+30.4%9.83Beat +4.6% est. 9.40
ANTHEM Anthem Biosciences LtdHealthcare418down−22.6%down−31.6%120down−11.8%2.13Beat +18.3% est. 1.80
MOLBIO Molbio Diagnostics LtdHealthcare408up+329.9%down−7.0%53n/a5.02No estimate
HIKAL Hikal LtdHealthcare403up+5.9%down−22.4%−7n/a−0.60No estimate
SOLARA Solara Active Pharma Sciences LtdHealthcare382up+19.7%down−1.3%16up+45.5%3.38No estimate
PGHL Procter & Gamble Health LtdHealthcare364up+7.3%down−1.7%96up+45.7%57.92No estimate
ACUTAAS Acutaas Chemicals LtdHealthcare330up+59.4%down−23.8%75up+70.5%9.07No estimate
ORCHPHARMA Orchid Pharma LtdHealthcare304up+15.6%down−17.4%3n/a0.63No estimate
BLUEJET Blue Jet Healthcare LtdHealthcare293down−17.5%up+24.7%78down−14.3%4.51Beat +7.4% est. 4.20
BLISSGVS Bliss GVS Pharma LtdHealthcare286up+38.0%up+11.1%51up+16.8%4.72No estimate
CONCORDBIO Concord Biotech LtdHealthcare261up+27.9%down−19.9%61up+41.9%5.85No estimate
GUFICBIO Gufic BioSciences LtdHealthcare261up+14.9%up+3.5%22up+85.9%2.24No estimate
WINDLAS Windlas Biotech LtdHealthcare248up+18.1%up+4.2%18down−1.9%8.55No estimate
SANOFICONR Sanofi Consumer Healthcare India LtdHealthcare236up+6.8%up+3.1%69up+13.1%29.87No estimate
FREDUN Fredun Pharmaceuticals LtdHealthcare228up+90.0%up+7.0%13up+85.7%7.98No estimate
BI Bilcare LtdHealthcare226up+21.5%up+20.2%15n/a5.39No estimate
JSLL Jeena Sikho Lifecare LtdHealthcare224up+29.0%up+3.9%66up+29.2%5.28No estimate
SYMBIOTEC Symbiotec Pharmalab LtdHealthcare218up+7.5%down−11.0%14down−53.1%2.24No estimate
SYMBIOTEC Symbiotec Pharmalab LtdHealthcare218up+7.4%down−11.0%14down−53.3%2.24No estimate
SMSPHARMA SMS Pharmaceuticals LtdHealthcare207up+5.6%down−13.0%21up+5.0%2.23No estimate
PANACEABIO Panacea Biotec LtdHealthcare200up+19.7%up+19.7%2down−44.4%0.38No estimate
RPGLIFE RPG Life Sciences LtdHealthcare196up+15.8%up+10.6%31up+18.3%18.48No estimate
ANUHPHR Anuh Pharma LtdHealthcare194up+4.2%down−4.1%11up+42.8%1.14No estimate
INDSWFTLAB Ind-Swift Laboratories LtdHealthcare191up+25.1%up+12.6%25up+174.3%2.84No estimate
ADVENZYMES Advanced Enzyme Technologies LtdHealthcare190up+2.0%down−6.5%39down−3.5%3.31No estimate
SUPRIYA Supriya Lifescience LtdHealthcare190up+30.9%down−31.5%24down−31.3%2.99No estimate
SENORES Senores Pharmaceuticals LtdHealthcare180up+30.4%up+2.9%30up+42.9%6.67No estimate
VENUSREM Venus Remedies LtdHealthcare179up+30.7%down−30.9%23up+130.0%17.18No estimate
SAIPARENT Sai Parenterals LtdHealthcare179up+435.1%down−9.7%8up+457.9%1.79No estimate
LINCOLN Lincoln Pharmaceuticals LtdHealthcare177up+15.1%down−5.2%36up+29.4%18.09No estimate
ZOTA Zota Health Care LtdHealthcare174up+66.9%up+6.5%−44n/a−12.58No estimate
BAJAJHCARE Bajaj Healthcare LtdHealthcare166up+11.4%up+8.5%14up+16.7%4.07No estimate
WANBURY Wanbury LtdHealthcare166up+1.5%up+0.6%3down−76.0%0.93No estimate
KPL Kwality Pharmaceuticals LtdHealthcare162up+45.9%up+3.2%26up+116.7%24.69No estimate
SUDEEPPHRM Sudeep Pharma LtdHealthcare158up+26.6%down−13.0%41up+30.9%3.59No estimate
KOPRAN Kopran LtdHealthcare154up+13.9%down−34.2%7down−10.1%1.39No estimate
NGLFINE NGL Fine Chem LtdHealthcare139up+37.8%down−4.0%18up+130.0%26.63No estimate
BETA Beta Drugs LtdHealthcare126up+26.0%up+34.0%16up+33.3%14.25No estimate
SYNCOMF Syncom Formulations (India) LtdHealthcare126up+7.3%down−6.3%25up+55.3%0.26No estimate
FERMENTA Fermenta Biotech LtdHealthcare122down−10.6%up+0.2%10down−55.9%3.31No estimate
SIGACHI Sigachi Industries LtdHealthcare121down−5.4%down−0.5%8n/a0.18No estimate
VALIANTLAB Valiant Laboratories LtdHealthcare115up+145.3%up+25.3%21up+955.2%3.88No estimate
TARSONS Tarsons Products LtdHealthcare110up+20.7%down−8.8%−1down−181.1%−0.27No estimate
SYSCHEMINDIALTD Syschem (India) LtdHealthcare109down−0.1%down−50.2%−2down−200.0%−0.34No estimate
VIMTALABS Vimta Labs LtdHealthcare109up+11.2%0.0%21up+10.5%4.71No estimate
NOVARTIND Novartis India LtdHealthcare104up+18.2%up+14.3%32up+14.3%13.05No estimate

About Q1 FY27 earnings data

When are Q1 FY27 results announced?
Q1 FY27 covers the Apr–Jun 2026 quarter. Indian listed companies have up to 45 days after a quarter closes to file their results — 60 days for the January–March quarter — so results arrive in a wave over the weeks that follow rather than all at once. A quarter that has only just ended will look sparse and fill in.
How many companies have declared Q1 FY27 results so far?
4,798 of 4,801 companies expected to report this quarter have filed. The rest are still to come; the count updates as filings land.
Why do some Q1 FY27 growth figures show "n/a" instead of a percentage?
Growth is left blank whenever the comparison period was not profitable. A percentage change measured from a loss is arithmetic without meaning — a swing from a ₹10 crore loss to a ₹10 crore profit is not "200% growth", and publishing it as such would flatter the company. The reported figures for both periods are still shown, so the change is there to read directly.
Does the beat/miss verdict cover every company?
No, and the denominator matters. An analyst consensus existed for 409 of the 4,798 companies that reported Q1 FY27 — 8.5%. Beat, missed and in-line describe only those. Every other company is marked "no estimate" rather than being counted as in line, because nobody forecast it. Revenue and profit growth, by contrast, cover every company in the table.
What counts as an in-line result rather than a beat or a miss?
Reported earnings per share within ±2% of the consensus estimate. The band is set there because a tighter one classifies rounding as news, and a wider one swallows surprises that genuinely moved a stock.
Are the figures consolidated or standalone?
Consolidated where a company reports on that basis, standalone otherwise, with all money in ₹ crore. Figures are as filed by the company with the exchanges (NSE/BSE); they are not restated or adjusted.
What does the 8-quarter trend line show?
Quarterly net profit for the last eight quarters, oldest on the left, always ending on the quarter shown in the row. Two years covers both the seasonal shape of the business and its direction. The line breaks where a quarter is missing rather than drawing across the gap, so a break is a real absence of data and not a reported collapse.
How do I find only the companies that beat estimates in Q1 FY27?
Use the Result filter above the table and choose Beat, or sort by EPS surprise to rank every covered company by how far it landed from consensus. Both are reflected in the page URL, so a filtered view can be bookmarked or shared.

Figures are as reported by companies in their quarterly filings to the exchanges (NSE/BSE), in ₹ crore. Consolidated results are shown where a company reports them, otherwise standalone. Year-on-year and quarter-on-quarter growth is omitted where the comparison period was loss-making, since a percentage change from a negative base is not meaningful. Analyst consensus is an estimate, not a forecast of outcome.